 Interferon advanced colorectal carcinoma Assessment activity toxicity Preclinical data cytotoxic effects interferon IFN small study patients advanced colorectal cancer regimen IFN dose schedule pilot study untreated patients metastatic colorectal carcinoma continuous intravenous IV infusion days weekly bolus subcutaneous IFN units times week evaluable patients partial response confidence limit median response duration months range months Seven patients minor response ten stable disease common toxicities stomatitis diarrhea Neurotoxicity patients gait disturbance dizziness confusion memory loss dementia toxicity patients reduction IFN dose reduction dose combination IFN patients advanced colorectal carcinoma activity regimen toxic observed response rate superior programs